Depletion of lncRNA MEG3 Ameliorates Imatinib-Induced Injury of Cardiomyocytes via Regulating miR-129-5p/HMGB1 Axis
Imatinib is a classical targeted drug to treat chronic myeloid leukemia (CML). However, it shows cardiotoxicity, which limits its clinical application. Long noncoding RNA (lncRNA) maternally expressed gene 3 (MEG3) shows proapoptotic properties in human cells. This study is performed to investigate...
Saved in:
| Main Authors: | Peng Tang, Jinjian Zhou, Huagang Liu, Shenglan Mei, Kai Wang, Hao Ming |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2023/1108280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients
by: Hadeer Saied Mahmoud, et al.
Published: (2025-07-01) -
Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers
by: Reem A. Assal, et al.
Published: (2025-04-01) -
LncRNA CAIF suppresses LPS‐induced inflammation and apoptosis of cardiomyocytes through regulating miR‐16 demethylation
by: Yan Wang, et al.
Published: (2021-12-01) -
LncRNA MEG3 exacerbates diabetic cardiomyopathy via activating pyroptosis signaling pathway
by: Shengnan Zhuo, et al.
Published: (2025-04-01) -
Lnc-MEG8 regulates yak myoblast differentiation via the miR-22-3p/RTL1 axis
by: Xiaoming Ma, et al.
Published: (2024-11-01)